Archive · 18 Nov 2025
Cancer Breakthroughs: Prevention, Detection, and Treatment
Scientists in the UK are working on new ways to stop cancer before it starts, find it early, and treat it better.
These include vaccines, special blood tests, and personalized treatments.
While there's still a lot to do, these advancements give us more hope in fighting cancer.
Three British researchers are leading breakthroughs in cancer prevention, detection, and treatment.
LungVax, a preventive vaccine, will enter human trials in 2026.
Cambridge-led 5G platform study offers personalized brain tumor treatment.
Liquid-biopsy technologies in Manchester enable early cancer detection.
Global acceleration in cancer innovation, with over 120 RNA cancer vaccine trials underway.
- Who
- Three British researchers: Professor Sarah Blagden, Professor Richard Mair, and Professor Caroline Dive
- What
- Leading breakthroughs in cancer prevention, detection, and treatment
- When
- LungVax trials start in 2026, other technologies steadily moving into clinical practice
- Where
- United Kingdom
- Why
- To redefine how cancer is prevented, detected, and treated
Optimistic View
Cautious View
Clinical Trial Success
Optimistic View
Many breakthroughs have shown promise in clinical trials.
Cautious View
Many breakthroughs fail in clinical trials due to cancer's complexity.
Accessibility
Optimistic View
Personalized mRNA vaccines could be widely accessible due to NHS centralization.
Cautious View
Personalized mRNA vaccines can cost more than $100,000, raising accessibility concerns.
- Vaccine Name
- LungVax
- Expected Human Trials
- 2026
- Brain Tumor Treatment
- Personalized therapy using AI
- Cancer Types Detected by Liquid Biopsy
- 50 types with low false-positive rates
- Colorectal Cancer Detection Accuracy
- 95% using RNA-based assays
- Global RNA Cancer Vaccine Trials
- Over 120 underway